Paul Grint

1.4k total citations
30 papers, 792 citations indexed

About

Paul Grint is a scholar working on Epidemiology, Immunology and Hepatology. According to data from OpenAlex, Paul Grint has authored 30 papers receiving a total of 792 indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Epidemiology, 12 papers in Immunology and 6 papers in Hepatology. Recurrent topics in Paul Grint's work include Hepatitis C virus research (6 papers), Respiratory viral infections research (4 papers) and Bacteriophages and microbial interactions (4 papers). Paul Grint is often cited by papers focused on Hepatitis C virus research (6 papers), Respiratory viral infections research (4 papers) and Bacteriophages and microbial interactions (4 papers). Paul Grint collaborates with scholars based in United States, United Kingdom and Netherlands. Paul Grint's co-authors include Edward Keystone, Steven M. Opal, Robert T. Schooley, Susan M. Lehman, Sandra Morales, Saima Aslam, Gordon Yung, Cathy Logan, Nancy Law and David L. Cutler and has published in prestigious journals such as Gastroenterology, Hepatology and Clinical Infectious Diseases.

In The Last Decade

Paul Grint

29 papers receiving 759 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Paul Grint United States 13 244 200 167 149 102 30 792
Jason D. Bannan United States 13 210 0.9× 146 0.7× 116 0.7× 360 2.4× 124 1.2× 18 998
David E. Justus United States 15 255 1.0× 206 1.0× 67 0.4× 172 1.2× 79 0.8× 30 789
Janine Zahlten Germany 20 471 1.9× 287 1.4× 84 0.5× 490 3.3× 67 0.7× 32 1.2k
Lijun Zhou China 15 232 1.0× 107 0.5× 57 0.3× 334 2.2× 65 0.6× 40 938
Karen L. Denzler United States 12 471 1.9× 289 1.4× 45 0.3× 275 1.8× 166 1.6× 19 1.3k
J. B. Hertz Denmark 18 113 0.5× 136 0.7× 66 0.4× 198 1.3× 74 0.7× 48 857
Patrick N. Nation Canada 19 184 0.8× 291 1.5× 46 0.3× 177 1.2× 282 2.8× 45 1.1k
Mónica G. Chiaramonte United States 18 711 2.9× 515 2.6× 103 0.6× 218 1.5× 56 0.5× 29 2.0k
Siân Jones United States 16 367 1.5× 210 1.1× 53 0.3× 332 2.2× 49 0.5× 23 1.4k
Riccardo Guidi Sweden 10 169 0.7× 66 0.3× 78 0.5× 276 1.9× 108 1.1× 12 658

Countries citing papers authored by Paul Grint

Since Specialization
Citations

This map shows the geographic impact of Paul Grint's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Paul Grint with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Paul Grint more than expected).

Fields of papers citing papers by Paul Grint

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Paul Grint. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Paul Grint. The network helps show where Paul Grint may publish in the future.

Co-authorship network of co-authors of Paul Grint

This figure shows the co-authorship network connecting the top 25 collaborators of Paul Grint. A scholar is included among the top collaborators of Paul Grint based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Paul Grint. Paul Grint is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Law, Nancy, Cathy Logan, Gordon Yung, et al.. (2019). Successful adjunctive use of bacteriophage therapy for treatment of multidrug-resistant Pseudomonas aeruginosa infection in a cystic fibrosis patient. Infection. 47(4). 665–668. 187 indexed citations
2.
Law, Nancy, Cathy Logan, Susan M. Lehman, et al.. (2019). Successful Bacteriophage Therapy for Treatment of Multidrug-Resistant Pseudomonas aeruginosa Infection in a Cystic Fibrosis Patient. The Journal of Heart and Lung Transplantation. 38(4). S38–S38. 5 indexed citations
3.
Aslam, Saima, Susan Maddocks, Sandra Morales, et al.. (2018). 1642. Safety and Efficacy of Bacteriophage Therapy: Analysis of Clinical Case Series Data. Open Forum Infectious Diseases. 5(suppl_1). S47–S47. 4 indexed citations
4.
Lehman, Susan M., et al.. (2018). P084 Bacteriophage treatment of multidrug-resistant Pseudomonas aeruginosa pneumonia in a cystic fibrosis patient. Journal of Cystic Fibrosis. 17. S83–S83. 5 indexed citations
5.
6.
Rheault, Michelle N., Oliver Groß, Gerald B. Appel, et al.. (2016). SP120CHANGE IN GLOMERULAR FILTRATION RATE AND RENAL BIOMARKERS IN PATIENTS WITH CHRONIC KIDNEY DISEASE DUE TO ALPORT SYNDROME: INTERIM RESULTS FROM THE ATHENA STUDY, A PROSPECTIVELY DESIGNED NATURAL HISTORY STUDY. Nephrology Dialysis Transplantation. 31(suppl_1). i126–i126. 1 indexed citations
7.
8.
Cooper, Philip J., et al.. (2000). Recombinant Human Interleukin‐10 Fails to Alter Proinflammatory Cytokine Production or Physiologic Changes Associated with the Jarisch‐Herxheimer Reaction. The Journal of Infectious Diseases. 181(1). 203–209. 30 indexed citations
9.
McHutchison, John G., Gianluigi Giannelli, Lisa M. Nyberg, et al.. (1999). A Pilot Study of Daily Subcutaneous Interleukin-10 in Patients with Chronic Hepatitis C Infection. Journal of Interferon & Cytokine Research. 19(11). 1265–1270. 28 indexed citations
10.
Opal, Steven M., et al.. (1998). Interleukin-10: Potential Benefits and Possible Risks in Clinical Infectious Diseases. Clinical Infectious Diseases. 27(6). 1497–1507. 82 indexed citations
11.
Keystone, Edward, et al.. (1998). IL-10 AS A THERAPEUTIC STRATEGY IN THE TREATMENT OF RHEUMATOID ARTHRITIS. Rheumatic Disease Clinics of North America. 24(3). 629–639. 117 indexed citations
12.
Narula, S K, David L. Cutler, & Paul Grint. (1998). Immunomodulation of Crohn’s disease by Interleukin-10. Birkhäuser Basel eBooks. 49. 57–65. 14 indexed citations
13.
Wissing, Karl Martin, Emmanuel Morélon, Christophe Legendre, et al.. (1997). A PILOT TRIAL OF RECOMBINANT HUMAN INTERLEUKIN-10 IN KIDNEY TRANSPLANT RECIPIENTS RECEIVING OKT3 INDUCTION THERAPY1,2. Transplantation. 64(7). 999–1006. 42 indexed citations
14.
Granowitz, Eric V., Leland Shapiro, Edouard Vannier, et al.. (1996). Clinical, hematologic, and immunologic effects of interleukin-10 in humans. Journal of Clinical Immunology. 16(5). 291–303. 71 indexed citations
15.
Morris, David J., et al.. (1990). Cytomegalovirus, varicella-zoster virus, and Coxsackie B virus-specific IgM antibody responses in children with cancer. Serodiagnosis and Immunotherapy in Infectious Disease. 4(2). 115–120. 7 indexed citations
16.
Webster, Aaron, Paul Grint, Malcolm K. Brenner, H. G. Prentice, & Paul Griffiths. (1989). Titration of igg antibodies against varicella zoster virus before bone marrow transplantation is not predictive of future zoster. Journal of Medical Virology. 27(2). 117–119. 30 indexed citations
17.
Grint, Paul, et al.. (1989). Testing for hepatitis B surface antigen—a critical review. Serodiagnosis and Immunotherapy in Infectious Disease. 3(5). 293–297. 1 indexed citations
18.
Kitau, M. J., Paul Grint, R. B. Heath, & T. Chard. (1988). Serum alphafetoprotein levels in subjects infected with hepatitis B virus. Journal of Medical Virology. 26(4). 437–442. 16 indexed citations
19.
Murphy, Michael, Paul Metcalfe, Paul Grint, et al.. (1985). Cephalosporin‐induced immune neutropenia. British Journal of Haematology. 59(1). 9–14. 42 indexed citations
20.
Grint, Paul, et al.. (1982). The postnatal acquisition of factors which affect the influenza haemagglutination-inhibition test. Journal of Hygiene. 89(2). 329–334. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Jason D. Bannan Breakdown of academic impact, for papers by David E. Justus Breakdown of academic impact, for papers by Janine Zahlten Breakdown of academic impact, for papers by Lijun Zhou Breakdown of academic impact, for papers by Karen L. Denzler Breakdown of academic impact, for papers by J. B. Hertz Breakdown of academic impact, for papers by Patrick N. Nation Breakdown of academic impact, for papers by Mónica G. Chiaramonte Breakdown of academic impact, for papers by Siân Jones Breakdown of academic impact, for papers by Riccardo Guidi
Rankless by CCL
2026